Value-based healthcare looks at health outcomes of treatment relative to cost. In a series of reports that I edited we have examined the way in which value is interpreted across Europe, the extent to which European countries are adopting cost-effectiveness as a key criterion for assessing it, and the efforts to develop new models for pricing innovation.
- An introduction to value-based healthcare in Europe
- Value-based healthcare in Europe: Laying the foundation
- Value-based Health Assessment in Italy: A decentralised model
- Value-based healthcare in Germany: From free price-setting to a regulated market
- Value-based healthcare in Spain: Regional experimentation in a shared governance setting
- Value-based healthcare in France: A slow adoption of cost-effectiveness criteria
- Value-based healthcare in Portugal: Necessity is the mother of invention
- Value-based healthcare in the UK: A system of trial and error
- Anniversary: 10 years at The Economist Group
- Cancer preparedness in Latin America: The need to build on recent progress
- Index of Cancer Preparedness reveals huge gaps in health system readiness and governance
- Why the fight against non-communicable diseases starts in adolescence
- Sweden offers both best practice and room for improvement on value-based healthcare